VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY

被引：0
|
作者：
Gu, Phillip
Chhabra, Avneesh
Chhittajallu, Punya
Chang, Christopher
Mendez, Denisse
Gilman, Andrew
Fudman, David
Xi, Yin
Feagins, Linda
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷
关键词：
D O I：
10.1093/ibd/izaa347.112
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [21] Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
    Su, CY
    Salzberg, BA
    Lewis, JD
    Deren, JJ
    Kornbluth, A
    Katzka, DA
    Stein, RB
    Adler, DR
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2577 - 2584
  • [22] Hematologic improvement in response to anti-tumor necrosis factor (TNF) therapy with Remicade® in patients with myelodysplastic syndromes (MDS).
    Raza, A
    Lisak, LA
    Tahir, S
    Billmeier, JM
    Willmann, HS
    Bellak, DJ
    Alvi, MI
    Gezer, S
    Venugopal, P
    BLOOD, 2002, 100 (11) : 795A - 795A
  • [23] The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis
    Tikiz, Hakan
    Arslan, Oezlem
    Pirildar, Timur
    Tikiz, Canan
    Bayindir, Petek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (02): : 98 - 103
  • [24] Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agent
    Yamauchi, Paul S.
    Bissonnette, Robert
    Teixeira, Henrique D.
    Valdecantos, Wendell C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 612 - +
  • [25] Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis
    Zhou, Zheng-Yi
    Griffith, Jenny
    Ganguli, Arijit
    Du, Ella Xiaoyan
    Betts, Keith
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Risk Factors for Surgery in Patients with Intestinal Behcet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
    Han, So Jung
    Kang, Eun Ae
    Park, Jihye
    Park, Soo Jung
    Park, Jae Jun
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    YONSEI MEDICAL JOURNAL, 2023, 64 (02) : 111 - 116
  • [27] Population-Based Risk of Mycobacterial Infections Associated With Anti-Tumor Necrosis Factor (anti-TNF) Therapy in Older Patients in Ontario, Canada
    Brode, Sarah
    Jamieson, Frances
    Ng, Ryan
    Campitelli, Michael
    Kwong, Jeff
    Paterson, J.
    Li, Ping
    Marchand-Austin, Alexandre
    Bombardier, Claire
    Marras, Theodore
    CHEST, 2013, 144 (04)
  • [28] The Effect of Anti-Tumor Necrosis Factor Therapy on The Plasma Atherogenic Index in Rheumatic Diseases
    Cure, Osman
    Kizilkaya, Bayram
    Ciftel, Serpil
    Mercantepe, Filiz
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, : 269 - 275
  • [29] The Effect of Anti-Tumor Necrosis Factor Therapy on The Plasma Atherogenic Index in Rheumatic Diseases
    Cure, Osman
    Kizilkaya, Bayram
    Ciftel, Serpil
    Mercantepe, Filiz
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (04) : 269 - 275
  • [30] Association of persistence with anti-tumor necrosis factor (anti-TNF) therapy and health care costs in patients with psoriatic arthritis
    Tang, B.
    Rahman, M., I
    Meissner, B.
    Dabbous, O.
    Naim, A.
    Thompson, H. C.
    VALUE IN HEALTH, 2007, 10 (06) : A250 - A251
12345